163 related articles for article (PubMed ID: 38249413)
1. Impact of two COVID-19 lockdowns on HbA1c levels in patients with type 2 diabetes and associations with patient characteristics: a multicentre, observational cohort study over three years.
Schäfer I; Tajdar D; Walther L; Bittner L; Lühmann D; Scherer M
Front Public Health; 2023; 11():1272769. PubMed ID: 38249413
[TBL] [Abstract][Full Text] [Related]
2. Effects of Two COVID-19 Lockdowns on HbA1c Levels in Patients with Type 1 Diabetes and Associations with Digital Treatment, Health Literacy, and Diabetes Self-Management: A Multicenter, Observational Cohort Study Over 3 Years.
Tajdar D; Lühmann D; Walther L; Bittner L; Scherer M; Schäfer I
Diabetes Ther; 2024 Jun; 15(6):1375-1388. PubMed ID: 38642263
[TBL] [Abstract][Full Text] [Related]
3. Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period.
Al-Mutairi AM; Alshabeeb MA; Abohelaika S; Alomar FA; Bidasee KR
Front Endocrinol (Lausanne); 2023; 14():1068018. PubMed ID: 36817609
[TBL] [Abstract][Full Text] [Related]
4. The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes.
Sutkowska E; Marciniak DM; Sutkowska K; Biernat K; Mazurek J; Kuciel N
Endocrine; 2022 May; 76(2):273-281. PubMed ID: 35072900
[TBL] [Abstract][Full Text] [Related]
5. Impact of COVID-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus in Dubai.
Makki I; Alnoon N; Rahmani N; Almulla J; Alamiri A; Alfalasi A; Zidan M
Curr Diabetes Rev; 2022; 18(8):e081221198650. PubMed ID: 34879807
[TBL] [Abstract][Full Text] [Related]
6. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.
Biamonte E; Pegoraro F; Carrone F; Facchi I; Favacchio G; Lania AG; Mazziotti G; Mirani M
Endocrine; 2021 Jun; 72(3):604-610. PubMed ID: 33950348
[TBL] [Abstract][Full Text] [Related]
7. Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic.
Ali N; El Hamdaoui S; Nefs G; Tack CJ; De Galan BE
BMJ Open Diabetes Res Care; 2022 May; 10(3):. PubMed ID: 35606020
[TBL] [Abstract][Full Text] [Related]
8. Switching "Real-World" Diabetes Patients to Degludec from Other Basal Insulins Provides Different Clinical Benefits According to Their Baseline Glycemic Control.
Tentolouris N; Knudsen ST; Lapolla A; Wolden ML; Haldrup S; Schultes B
Adv Ther; 2019 May; 36(5):1201-1210. PubMed ID: 30879256
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes.
Duarte V; Mota B; Ferreira S; Costa C; Correia CC
Arch Pediatr; 2022 Jan; 29(1):27-29. PubMed ID: 34955306
[TBL] [Abstract][Full Text] [Related]
10. Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A
Tian J; Ohkuma T; Cooper M; Harrap S; Mancia G; Poulter N; Wang JG; Zoungas S; Woodward M; Chalmers J
Diabetes Care; 2020 Jun; 43(6):1293-1299. PubMed ID: 32193249
[TBL] [Abstract][Full Text] [Related]
11. Observational study on effect of lock down due to COVID 19 on HBA1c levels in patients with diabetes: Experience from Central India.
Khare J; Jindal S
Prim Care Diabetes; 2022 Dec; 16(6):775-779. PubMed ID: 33419712
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020.
Nwosu BU; Al-Halbouni L; Parajuli S; Jasmin G; Zitek-Morrison E; Barton BA
Front Endocrinol (Lausanne); 2021; 12():703905. PubMed ID: 34447352
[TBL] [Abstract][Full Text] [Related]
13. The Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes Mellitus: A Brief Report.
Vozza A; Porfido E; Delvino A; Custodero C; Lisco G; Triggiani V; Tortorella C; Piazzolla G
Endocr Metab Immune Disord Drug Targets; 2023; 23(8):1041-1045. PubMed ID: 36644863
[TBL] [Abstract][Full Text] [Related]
14. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CR; Leite NC; Ferreira MT; Salles GF
Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown.
Tanji Y; Sawada S; Watanabe T; Mita T; Kobayashi Y; Murakami T; Metoki H; Akai H
Diabetes Res Clin Pract; 2021 Jun; 176():108840. PubMed ID: 33933499
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 lockdown on glycaemic control and lifestyle changes in children and adolescents with type 1 and type 2 diabetes mellitus.
Cheng HP; Wong JSL; Selveindran NM; Hong JYH
Endocrine; 2021 Sep; 73(3):499-506. PubMed ID: 34244903
[TBL] [Abstract][Full Text] [Related]
18. Effect of the COVID-19 pandemic on glycemic control in Brazilian patients with type 2 diabetes.
Tannus LRM; Zapelini RM; Cabizuca CA; Abi-Abib RC; Matheus ASM; Calassara PC; Pozzan R; Cobas RA
Endocrine; 2022 Sep; 77(3):455-460. PubMed ID: 35838896
[TBL] [Abstract][Full Text] [Related]
19. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
[TBL] [Abstract][Full Text] [Related]
20. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
